Dimethyl Sulfoxide
Crescent Chemical Co Inc DIMETHYL SULFOXIDE
Dimethyl sulfoxide research grade Highly active solvent and pharmaceutical vehicle; for freezing cells. For gradient centrifugation (1). Determination of cysteine and cystine in proteins (2). Size - 250ML Storage Conditions - +15 °C TO +30 °C Catalog
Medchemexpress LLC Erdafitinib | 1346242-81-6 | 446.5 g/mol | 1 ML
Erdafitinib | 1346242-81-6 | 446.5 g/mol | 1 ML
Sigma Aldrich Fine Chemicals Biosciences Dimethyl sulfoxide United States Pharmacopeia (USP) Reference Standard | 67-68-5 | MFCD00002089 | 3G
Dimethyl sulfoxide United States Pharmacopeia (USP) Reference Standard | Mol Wt: 78.13 | 67-68-5 | MFCD00002089 | 3G
Apexbio Technology LLC EPZ-6438 1403254-99-8 10mM (in 1mL DMSO)
EPZ-6438 is a selective inhibitor targeting EZH2 the catalytic subunit of polycomb repressive complex 2 (PRC2) By competitively binding to EZH2 s S-adenosylmethionine (SAM) pocket EPZ-6438 suppresses EZH2-driven trimethylation of histone H3 lysine 27 (H3K27me3) a key epigenetic modification implicated in transcriptional regulation and oncogenesis This selective inhibition of EZH2 exhibits reduced affinity for EZH1 In biological studies EPZ-6438 has demonstrated anti-tumor activity in preclinical malignant rhabdoid tumor models making it useful for examining EZH2-dependent cancer pathways and epigenetic research
Apexbio Technology LLC CYT387 1056634-68-4 10mM (in 1mL DMSO)
CYT387 (CAS 1056634-68-4) is an aminopyrimidine derivative identified through high-throughput screening and optimized with structure-guided medicinal chemistry It functions as an inhibitor targeting Janus kinase family enzymes JAK1 JAK2 JAK3 and TYK2 with reported IC50 values of 11 nM 18 nM 155 nM and 17 nM respectively At concentrations between 500 1500 nM CYT387 selectively suppresses JAK2 signaling inhibits proliferation of JAK2-dependent hematopoietic cell lines and induces apoptosis with minimal effects on non-hematopoietic cells CYT387 is employed in experimental studies of JAK2-mediated signaling pathways and myeloproliferative neoplasms
Apexbio Technology LLC Olaparib (AZD2281, Ku-0059436) 763113-22-0 10mM (in 1mL DMSO)
Olaparib (AZD2281 Ku-0059436 CAS 763113-22-0) is a selective inhibitor of poly(ADP-ribose) polymerase-1 and -2 (PARP-1/2) By targeting PARP enzymes involved in DNA repair Olaparib specifically inhibits the proliferation of BRCA-deficient tumor cell lines and enhances radiosensitivity in experimental tumor models In xenograft mouse models of non-small cell lung carcinoma (NSCLC) Olaparib has been shown to elevate radiation sensitivity and improve tumor perfusion The compound is widely utilized in studies focused on DNA damage responses tumor radiosensitization and targeted therapy strategies for BRCA-associated cancers
Apexbio Technology LLC BMN 673 1207456-01-6 10mM (in 1mL DMSO)
BMN 673 (CAS 1207456-01-6) is a small-molecule inhibitor selectively targeting poly(ADP-ribose) polymerase isoforms PARP1 and PARP2 enzymes crucial for DNA repair pathways BMN 673 demonstrates potent inhibition with reported Ki values of 1 2 nM and 0 9 nM against PARP1 and PARP2 respectively and minimal off-target interactions across diverse receptors ion channels and enzymes In preclinical studies BMN 673 displayed substantial antitumor activity in tumor cells and xenograft models exhibiting homologous recombination repair deficits with enhanced efficacy noted in combination with DNA-damaging agents Currently BMN 673 is under clinical investigation in advanced solid tumors and hematological malignancies
Apexbio Technology LLC Avasimibe 166518-60-1 10mM (in 1mL DMSO)
Avasimibe (CAS 166518-60-1) is an orally bioavailable inhibitor of acyl-coenzyme A cholesterol acyltransferase (ACAT) an enzyme involved in cholesterol esterification It exhibits potent inhibition with an IC50 of approximately 60 nM In cell-based studies avasimibe reduces intracellular cholesterol esters in a dose-dependent manner without elevating free cholesterol levels suggesting an advantageous safety profile Additionally avasimibe reduces synthesis and secretion of Apo B 100 a constituent of very low-density lipoprotein (VLDL) in HepG2 cells and increases bile acid synthesis in rat hepatocytes Beyond dyslipidemic modulation and anti-atherogenic activities it influences amyloid precursor protein (APP) trafficking reducing its maturation and subsequent amyloid-beta (A ) peptide generation providing avenues for Alzheimer s disease research